Adults: Supraventricular arrhythmias: The recommended starting dose is 50 mg twice daily and most patients will be controlled at this dose. If required the dose may be increased to a maximum of 3000 mg daily.
Ventricular arrhythmias: The recommended starting dosage is 100 mg twice daily. The maximum daily dose is 400 mg and this is normally reserved for patients of large build of where rapid control of the arrhythmia is required.
After 3-5 days it is recommended that the dosage be progressively adjusted to the lowest level which maintains control of the arrhythmia. If may be possible to reduce dosage during long-term treatment.
Children: Tambocor is not recommended in children under 12, as there is insufficient evidence of its use in this age group.
Elderly patients: The rate of flecainide elimination from plasma may be reduced in elderly people. An initial dose of one tablet twice daily will usually be adequate, and it may well be possible to reduce this dose for maintenance therapy after one week.
Other Services
Country
Account